Summary of "Reply."
No Summary Available
National Center for Register-based Research, Aarhus University, Aarhus C, Denmark E-mail: firstname.lastname@example.org.
This article was published in the following journal.
Name: Acta psychiatrica Scandinavica
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/22616987
- DOI: http://dx.doi.org/10.1111/j.1600-0447.2012.01879.x
Medical and Biotech [MESH] Definitions
This is a reply to a comment on our previously published paper.
This is a reply to the comments made by Poli and Salvaris (2011 J. Neural Eng. 8 058001) regarding a recent study by Bradberry et al (2011 J. Neural Eng. 8 036010).
Nefrologia 2012;32(6):838-9. doi: 10.3265/Nefrologia.pre2012.Oct.11783. Reply to: Del Pozo et al. Comment on Nefrologia 2012;32(6):837. Nefrologia 2012; 32(4):419-26.
Nefrologia 2012;32(6):835-7. doi: 10.3265/Nefrologia.pre2012.Oct.11731. Reply to: Serra Tarragon. Comment on Nefrologia 2012;32(6):835. Nefrologia 2012; 32(4):419-26.
The aim of this study is to assess the benefits from the AAISafeR/SafeR algorithm of Symphony 2550 or REPLY DR in a wide range of pacemaker patients. The expected benefits will be a resul...
A pharmacist follow-up procedure is under development. Patients with coronary heart disease (CHD) is being followed up by a pharmacist for one year with three meetings; at discharge from h...
Recent studies have shown the importance of preserving spontaneous atrio-ventricular conduction in patients implanted with an implantable cardiac pacemaker. The SafeR/AAISafeR pacing mode...